Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions

In treatment or prevention of COVID-19, ivermectin is not approved by the United States (US) Food and Drug Administration (FDA). Nonetheless, in the US, prescriptions of ivermectin by healthcare providers have increased > tenfold from 3589 per week pre-COVID-19 to 39,102. Ivermectin is FDA approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Molnar, Andreea, Lau, Stephanie, Berges, Maja, Masa, Raymond B., Solano, Joshua J., Alter, Scott M., Clayton, Lisa M., Shih, Richard D., DeMets, David L., Maki, Dennis G., Hennekens, Charles H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086156/
https://www.ncbi.nlm.nih.gov/pubmed/35147927
http://dx.doi.org/10.1007/s43441-022-00378-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086156/
https://www.ncbi.nlm.nih.gov/pubmed/35147927
http://dx.doi.org/10.1007/s43441-022-00378-0

Ejemplares similares